Tumor cell dormancy has also been described in transgenic mouse models for breast cancer, in which polyoma middle-T antigen or ERBB2 signaling was studied in mammary gland tissue that was devoid of β1 integrin80. This evidence concerns the gene ERBB2 and breast cancer.